What is the recommended nitazoxanide dose in mg per kilogram of body weight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nitazoxanide Dosing by Weight

The recommended nitazoxanide dose is 7.5 mg/kg orally twice daily for children ages 1-3 years, 100 mg (5 mL) twice daily for children 4-11 years, and 500 mg twice daily for patients ≥12 years of age, all administered with food for 3 days. 1

Age-Based Dosing Algorithm

The FDA-approved dosing is stratified by age rather than strict weight-based calculations for most patients:

Pediatric Patients (1-11 years)

  • Ages 1-3 years: 100 mg (5 mL of oral suspension) twice daily = approximately 7.5 mg/kg twice daily 2
  • Ages 4-11 years: 200 mg (10 mL of oral suspension) twice daily 1

Adolescents and Adults (≥12 years)

  • 500 mg twice daily (either tablets or 25 mL oral suspension) 1

Critical Administration Details

Always administer with food - this is non-negotiable. Food increases the AUC of the active metabolite (tizoxanide) by 45-50%, which is essential for therapeutic efficacy. 1 The clinical trials that established efficacy used food-accompanied administration, making this a requirement rather than a suggestion.

Treatment Duration

  • Standard course: 3 days for both Giardia lamblia and Cryptosporidium parvum infections 1
  • Dosing interval: Every 12 hours (twice daily) 1

Important Clinical Caveats

Formulation Restrictions

  • Tablets contain too much drug for children ≤11 years - use oral suspension only in this age group 1
  • A single 500 mg tablet exceeds recommended pediatric dosing

Population-Specific Limitations

  • Not studied in infants <1 year of age - safety and efficacy unknown 1
  • HIV-infected/immunodeficient patients: Not shown superior to placebo for C. parvum treatment; efficacy data for G. lamblia in this population is lacking 2, 1
  • Renal/hepatic impairment: Pharmacokinetics unstudied - use with caution 1

Drug Interactions

Monitor closely when co-administering with highly protein-bound drugs with narrow therapeutic indices (e.g., warfarin), as tizoxanide is >99.9% protein-bound and may compete for binding sites 1

Comparative Efficacy Context

Research suggests nitazoxanide at 7.5 mg/kg twice daily for 3 days achieves approximately 78-84% parasitological cure rates for giardiasis 3, which is slightly lower than single-dose tinidazole (90.5%) but remains clinically acceptable. The drug is well-tolerated with only mild, self-limited side effects (primarily abdominal pain, headache, nausea) 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.